Kurma Partners — 2021 Investments
6 investments dated 2021 · listed companies and verified rows first · show all
Corteria Pharma develops interceptive therapies aimed at treating subpopulations of patients with heart failure, sarcopenia, and obesity.
BiotechDigital HealthHealthtechLongevity
Philip JaniakinMarie-Laure OzouxinRégis OlivierinFrancesca C. LawsonMark KowalaEleonore Jouannyin
Co-investorsFountain Healthcare PartnersJeito CapitalOrbiMedV-Bio VenturesOmnes CapitalInvivo Capital Partners+1 more
Step Pharma develops oral cancer drugs that inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1), with its lead therapeutic dencatistat in clinical development for lymphoma, solid tumors, and essential thrombocythaemia.
BiotechDeep TechMedical DevicesSaint-Genis-Pouilly, FR
Alain Fischer(Founding Scientist)
Co-investorsHadean VenturesBpifranceAgoranovPontifax Venture CapitalSunstone CapitalV-Bio Ventures
Co-investorsNewfund Capital
IOBiotech appears to be a biotech company focused on oncology, with a founder who has extensive experience in cancer drug development and clinical advancement from roles at Roche, Eli Lilly, and leading academic cancer centers.
BiotechMedical Devices
Dr. Dhingra
Co-investorsAvoro Capital AdvisorsEIR VenturesPivotal Life SciencesRA CapitalSamsara BioCapitalSunstone Capital+3 more
Sunrise AI designs, deploys, and operates custom AI systems inside client businesses, connecting to their proprietary data and workflows to build an "AI operating layer" starting with a single high-impact workflow.
AI & Machine LearningEnterprise SoftwareSaaS
Co-investorsAI FundSambrinvestSeventure PartnersVIVES Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Emergence Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
















